Global Business Magazine

ATLANTA, May 18, 2026 (GLOBE NEWSWIRE) — HUANUO, a global leader in ergonomic solutions for office and gaming, today announces that it has debuted a new FlowLift™ Pro series of monitor arms at DreamHack Atlanta 2026 to address the growing needs of gaming ergonomics. The series integrates four innovative technologies to address common pain points in monitor arm use, including screen sagging, durability, adjustability, and setup friction, bringing a professional ergonomic experience to gamers and content creators. FlowLift™ Pro Monitor…

The myasthenia gravis market size reached approximately USD 6 billion in 2025 across the 7MM and is growing at a robust CAGR of 9.1% during the forecast period. This remarkable growth is being underpinned by surging diagnosed prevalence, a rapidly evolving pipeline of targeted therapies, including Immunovant/Roivant Sciences’ IMVT-1402, Cartesian Therapeutics’ Descartes-08, Novartis’ FABHALTA, Alexion AstraZeneca Rare Disease’s Gefurulimab, RemeGen/Vor Bio’s Telitacicept, and others.New York, USA, May 18, 2026 (GLOBE NEWSWIRE) — Myasthenia Gravis Market Set to Surpass USD 16…

MONACO CITY, Monaco , May 17, 2026 (GLOBE NEWSWIRE) — Crypto news today is turning toward AlphaPepe after the project announced that Stage 16 is nearing sell-out while the presale remains live at $0.01717 per token. The project has raised over $1.25 million, the holder count has passed 8,700, the AlphaSwap AI DEX demo has surpassed 4,000 active users, and AlphaPepe has completed a full 10/10 BlockSAFU security audit ahead of its planned Q2 2026 exchange debut. The Stage…

MONACO CITY, Monaco, May 17, 2026 (GLOBE NEWSWIRE) — Crypto news today is turning toward AlphaPepe after the project announced that its presale has raised over $1.25 million while Stage 16 remains live at $0.01717 per token. The holder count has passed 8,700, the AlphaSwap AI DEX demo has surpassed 4,000 active users, and the project has completed a full 10/10 BlockSAFU security audit ahead of its planned Q2 2026 exchange debut. The $1.25 million milestone gives AlphaPepe a…

Data presented by Johnson & Johnson at the 2026 European Society for Radiotherapy and Oncology (ESTRO) Annual MeetingPARIS and CAMBRIDGE, Mass., May 17, 2026 (GLOBE NEWSWIRE) —  NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – the “Company”), a late-clinical stage biotechnology company pioneering nanotherapeutic approaches to expand treatment possibilities for patients with cancer and other major diseases, today announced the presentation of Part 1 data from the CONVERGE study, a Johnson & Johnson-sponsored randomized Phase 2 clinical trial evaluating potential first-in-class…